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This article describes apparatus to aid histological validation of magnetic resonance 
imaging studies of the human prostate. The apparatus includes a 3D-printed patient- 
specific mold that facilitates aligned in vivo and ex vivo imaging, in situ tissue fixation, and 
tissue sectioning with minimal organ deformation. The mold and a dedicated container 
include MRI-visible landmarks to enable consistent tissue positioning and minimize 
image registration complexity. The inclusion of high spatial resolution ex vivo imaging 
aids in registration of in vivo MRI and histopathology data.
Keywords: prostate, prostate cancer, MRI validation, in vivo MRI, ex vivo MRI, histology, co-registration, fixation
1. the Need FoR hIstoLoGICAL VALIdAtIoN oF MRI
Imaging provides valuable non-invasive information for diagnosis and treatment of prostate cancer. 
The current state of the art is multi-parametric MRI (mp-MRI) (1), although even this lacks specific-
ity and cannot provide reliable grading information. Advanced techniques (2, 3) show promise for 
probing cancer microstructure and may be more specific than conventional methods. However, 
rigorous validation is needed to assess the current and potential value of such techniques in prostate 
cancer management. The current gold standard for validation is histological assessment of whole 
mount serial sectioned radical prostatectomy specimens, but comparing information from such 
disparate images presents several challenges.
Below we give an overview of these challenges and the current methods for addressing some of 
them. Then, we describe a mold-based apparatus and imaging protocol that include ex vivo imaging 
and a number of innovations that improve alignment of imaging and histology planes and minimize 
in-plane rotational differences to improve the quality of the 2D registration processes. The apparatus 
also allows for the collection of supplementary ex vivo MR data for both the fresh unfixed and the 
fixed prostate specimen.
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2. PRoBLeMs IN hIstoLoGICAL 
VALIdAtIoN oF MRI Methods
There are a number of major technical problems complicating any 
attempt to directly match and correlate MRI and histology data 
(4). These difficulties include
•	 Unmatched tissue planes. In practice there is usually no direct 
coordination of presurgical imaging methods and surgical 
specimen processing. This results in MRI slice planes usually 
having different plane orientation and plane spacing from the 
histology images with no clear correspondence between the 
two so that, at best, only a qualitative correlation of MRI and 
pathology data is feasible.
•	 Unmatched spatial resolution. A volume element (“voxel”) 
in prostate MRI (the source of each semi-discrete item of 
measurement data) has a typical size that may vary from 
0.2  mm  ×  0.2  mm in-plane by 1  mm slice thickness to 
2 mm × 2 mm in-plane by 5 mm slice thickness. By contrast, 
a typical histological image used for pathology assessment is 
based on a 3–5  µm thick tissue section and has an in-plane 
resolution <1  µm. Even under highly idealized conditions, 
where the histology and MRI slices are “co-planar,” the MRI 
signal originates from a much larger tissue volume than is 
represented in the histology slice. Thus, there may be tissue 
structure heterogeneity within the MRI slice that is not 
reflected in the histological data.
•	 Tissue deformations. The prostate is deformed in vivo by vol-
untary and involuntary body movements, bowel contents, and 
by the imaging system itself if an endorectal coil is employed 
for signal detection. Upon resection, the prostate is detached 
from its supporting tissues and associated vasculature, result-
ing in shape changes due to removal of mechanical tension and 
compression and hemodynamic pressure (5). Dehydration 
and embedding of the tissue during processing for histology 
results in tissue shrinkage and thin sectioning may cause 
further deformations.
•	 Unmatched image features. MRI and histological staining 
produce image contrast according to very different tissue 
properties. The features present in MR images may not be 
easily identified in histology images and vice  versa, leading 
to a difficulty in assessing the accuracy of any co-registration 
process.
3. sURVeY oF Methods
The validation problems mentioned earlier have been addressed 
with varying degrees of completeness by various methods, some 
of which have been reviewed in Ref. (4, 6). Here, we provide a 
brief overview of the approaches and problems addressed by the 
method we describe.
A partial 3D histology “map” can be reconstructed from a 
stack of histology slices and registered with MR images by a 3D 
process (7, 8); however, the accuracy of this approach is severely 
limited by the low out of plane resolution of the MRI data. The 
problem of missing inter-plane histology data can be addressed 
by manual (9, 10) or automatic (11) selection of the most closely 
aligned histology and image planes. Ideally, this reduces the prob-
lematic 3D registration to a more tractable 2D process. As the 
accuracy of this approach is highly dependent on co-alignment 
of imaging planes with histology sections, a number of methods 
have been described based on production of a patient-specific 
3D-printed mold, the shape of which is defined by the in  vivo 
imaging data. The aim of the mold is to hold the prostate in the 
same conformation in which it was imaged while guides in the 
mold align the tissue cutting planes with the image slice positions 
(12–15). The precision of these mold-based methods is depend-
ent on the degree to which the mold matches the shape of the 
excised prostate specimen and the amount of any mispositioning 
or rotation of the prostate in the mold. Rotation errors are more 
likely around the axes in which the specimen has greatest rota-
tional symmetry. Inclusion of a urethral catheter in the specimen 
and mold design can decrease rotation errors about the left–right 
axes of the prostate (6).
High spatial resolution ex vivo imaging of the prostate speci-
men has been used as an intermediate “stepping-stone” to improve 
the accuracy of co-registration of in vivo MRI and histology data, 
both with (6) and without (16) a patient-specific mold. However, 
the mold design can be improved to better facilitate comparison 
between MR and histological images.
4. oUtLINe oF IMAGING ANd sPeCIMeN 
hANdLING
The following points outline the method of imaging and con-
struction of a patient-specific 3D-printed mold to optimize 
physical location of the prostate in in vivo MR images, ex vivo MR 
images, and histology images. The aim is to reduce the inherent 
3-dimensional co-registration problem to a more tractable and 
precise 2-dimensional process.
4.1. In Vivo Imaging
This study was carried out in accordance with the recommenda-
tions of the UK Research Governance Framework version 2, UK 
Research Ethics Committee with written informed consent from 
all subjects and approved by the NRES Committee London-Surrey 
Borders (REC 15/LO/0692). All subjects gave written informed 
consent in accordance with the Declaration of Helsinki.
The geometry for the in vivo imaging needs to be compatible 
with the local clinical histopathology processing and reporting 
protocol. In our case, the pathology department uses 5 mm thick 
sections cut approximately transaxial to the prostatic urethra and 
perpendicular to the posterior face of the prostate. We perform 
T2-weighted imaging with 2.5 mm slice thickness (with no gap or 
2.5 mm gap) in the “true axial” scanner XY plane. The central slice 
is centered approximately mid-organ and is defined as the refer-
ence for all subsequent imaging and processing and is defined by 
MR visible landmarks in the patient-specific mold.
For the data illustrating the methods in this paper mp-MRI 
was performed on a 3-T scanner (Achieva, Philips, Best, the 
Netherlands), using pelvic phased array coils. The 0.2  mg/kg 
(up to 20  mg) of a spasmolytic agent (Buscopan; Boehringer 
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Ingelheim, Germany) was administered intravenously prior to 
imaging to reduce bowel peristalsis. mp-MRI comprises axial 
and coronal T2 turbo spin echo (TSE) imaging, supplemented 
with diffusion-weighted imaging at b-values 0, 150, 500, and 
1,000 s/mm2. A dynamic contrast enhanced (DCE) acquisition 
was subsequently performed using spoiled gradient echo with 
fat saturation and a 12-s time resolution. Intravenous contrast 
agent (0.2 mL/kg; Prohance, Bracco, Milan, Italy) was injected at 
the beginning of the 6th acquisition at 3 mL/s followed by 20 mL 
of saline.
4.2. Contouring of In Vivo Images for 
Patient-specific Mold specification
MR datasets were analyzed using Osirix Version 7.0 (Bernex, 
Switzerland). A board certified Radiologist (Edward William 
Johnston) manually contoured the entire prostate (from base 
to apex) using the closed polygon tool on high-resolution 
axial T2-weighted images. Contoured landmarks comprise 
the hypointense prostate capsule and the anterior fibro-
muscular stroma where the capsule is absent anteriorly. The 
periprostatic fat, neurovascular bundles, seminal vesicles, 
distal urethral sphincter, and bladder were not included inside 
the contoured volume but provided useful information as to 
the extent of the prostate. The positions of contours were 
checked in all planes and adjusted accordingly until their 
appearance was satisfactory. Where available, at least 3 slices 
of coronal and/or sagittal images were contoured at the center 
of the gland to corroborate axial contours, but the edge of the 
prostate was not contoured as it is poorly delineated in these 
planes. To estimate urethral catheter position, the urethra was 
demarcated where visible using axial T2-weighted images and 
interpolating based on normal anatomy and adjacent slice 
position where invisible.
4.3. Prostatectomy and specimen 
Preparation
The radical prostatectomy specimen was collected immediately 
upon resection to minimize ischemia time and taken to the 
pathology department without formalin fixation. The fresh 
specimen was inked and dried, and the seminal vesicles and any 
metal clips that would cause magnetic susceptibility artifacts were 
removed. A 4.2-mm diameter silicon rubber catheter was inserted 
through the urethra, the prostate placed into the mold, and the 
mold halves fastened with four plastic cable ties. The specimen 
inside the closed mold was then inserted into the canister, which 
had been pre-filled with saline. Gentle agitation was used to 
eliminate air bubbles, and then the sealing piston was inserted 
fully to ensure alignment of the mold reference plane with the 
external reference landmarks. Excess fluid was ejected through 
the vent, which was then capped.
4.4. Ex Vivo Prostate Imaging
Fresh ex vivo scanning was performed on both a 3-T clinical 
MRI scanner (Philips Achieva, Best, the Netherlands) and a 
9.4-T 20-cm horizontal bore MRI (Varian Inc., Palo Alto, CA, 
USA). Fixed imaging was conducted only at 9.4 T. The reference 
plane landmarks on the exterior of the mold canister (see section 
6 below) were used to position the reference slice of the sample 
near the isocenter of the magnet.
For 3-T MRI, the sample was positioned at the center of an 
8-channel knee coil (Philips, Best). T2-weighted TSE images 
(TE = 100 ms, echo train length = 16, TR = 5.2 s, field of view 
18 cm × 18 cm) were acquired with 0.4 mm × 0.4 mm resolution 
in-plane, 2 mm slice thickness, and 0.5 mm slice gap.
Imaging at 9.4 T was performed using 400 mT/m gradients 
and a 72  mm internal diameter quadrature coil (RAPID 
Biomedical, Rimpar, Germany). A multi-slice gradient echo 
sequence (TE = 5 ms, TR = 75 ms, field of view 8 cm × 8 cm) 
was acquired giving 0.625 mm × 0.625 mm in-plane resolution, 
1 mm slice thickness, and no slice gap. These images were used 
to locate the reference slice using the reference plane landmarks 
(see section 5.1 below), as shown in Figure 1. The same proce-
dure for reference slice location was repeated following specimen 
fixation.
5. MoLd desIGN ANd 3d PRINtING
5.1. Mold template
The mold template is 62 mm diameter, designed to fit inside a 
63.5  mm internal diameter canister that contains the prostate 
immersed in saline during ex vivo imaging. The mold design is 
based on the abilities and constraints of nylon powder printing 
(selective laser sintering using EOSINT P100 with PA2200 pow-
der; 40–50 µm grain size). Note that the mold design described 
here could not be produced on a typical low-cost plastic filament 
printer due to the lower dimensional precision and the need for 
these devices to print support material that would be extremely 
difficult to remove from the design we describe. A more basic 
mold design suitable for a filament printer is described in Ref. (6). 
The mold features are illustrated in Figure 2 and include
•	 A chamfer at one end of the mold indicates the apex end of 
the prostate, so that orientation of the prostate during ex vivo 
imaging is as for in vivo imaging with the patient lying in feet-
first supine position.
•	 LP. Two 4-mm diameter locator pins ensure alignment of the 
mold halves.
•	 CP. Two 0.4-mm wide slots, spaced 5.0 mm apart, define the 
cutting planes for organ sectioning.
•	 B. 0.5-mm diameter braces stabilize the mold shape during ex 
vivo imaging. These are removed immediately prior to organ 
sectioning.
•	 RPLM. Reference plane land marks (1.5-mm diameter axial 
channels) are filled with liquid when the prostate and mold 
are inserted in the imaging canister and provide MR visible 
landmarks that enable precise matching of in vivo and ex vivo 
imaging planes. Relative to the cutting planes the landmarks 
are offset toward the apex of the prostate to bring the center 
of the MRI planes into closer alignment with the histology 
sections that are routinely cut from the apex face of the tissue 
blocks.
•	 U. A 4.2-mm diameter saline-filled silicon rubber urethral 
catheter is inserted in the prostate with curvature and 
FIGURe 1 | Images acquired at 1 mm spacing demonstrate the use of the reference plane landmark channels (some of which are obscured by air 
bubbles here) to locate the reference slice. When correctly positioned and aligned the reference image will show the water filled channels on the A/P and L/R 
sides of the prostate.
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orientation defined during contouring of the in vivo images. 
The catheter assists in constraining any rotations of the pros-
tate in the sagittal plane.
•	 S. Flexible springs printed into the mold press against the wall 
of the canister and minimize any movement or vibration of the 
mold in the canister during imaging.
•	 G. A groove in the top of the mold matches the internal rib in 
the canister (Figure 3) and precludes any rotation of the mold 
in the axial plane.
•	 CT. The corners of the mold halves are fastened with four 
plastic cable ties.
6. MoLd CoNtAINeR FoR EX VIVO 
IMAGING
For ex vivo imaging (both before and after formalin fixation), 
the specimen in the mold is constrained inside a plastic can-
ister. A liquid-tight seal is made with a piston that also serves 
as the mounting base for attachment of the sample to the 
scanner’s small animal bed. Details are described in Figure 3 
and below:
•	 Canister. The canister is 68  mm outside diameter, 63.5  mm 
internal, to fit with 2 mm clearance inside the 72 mm internal 
diameter RF coil used for 9.4-T ex vivo imaging. The canister 
is printed in rigid photopolymer (Objet, Stratasys), which is 
non-porous. Landmarks on the external surface of the canister 
define the position of the reference slice and top midline of 
the mold. An internal rib fits the groove in the top of the mold 
and prevents any rotation of the mold inside the canister, thus 
ensuring minimal axial plane rotational differences between 
in vivo and ex vivo images (see Figure 2).
•	 Piston. The canister is sealed liquid tight with a piston (also 
printed in rigid photopolymer) fitted with three O-rings lubri-
cated with light grease. To immerse the prostate in liquid and 
minimize inclusion of air bubbles the canister is placed verti-
cally and filled with 200 mL of saline. The prostate in the mold 
is inserted, pushed to the bottom of the canister, and agitated to 
expel air bubbles. The piston is then inserted and excess liquid 
is expelled into the central well via the vent which is then sealed 
with a plastic pin. The center line landmark (CL) on the piston 
is aligned with the center line mark on the canister. The fully 
inserted piston fixes the mold at the base of the canister, so that 
the mold reference plane is aligned with the external landmarks. 
The mold and prostate are thus fixed in a defined position rela-
tive to the external landmarks on the canister and piston.
•	 Mounting bracket. The base of the piston is attached to a 
mounting bracket that is designed specifically for the small 
animal bed of the MRI scanner. The bracket is printed on the 
SLS printer that provides a rigid product (slightly porous so 
unsuitable for canister and piston).
7. FoRMALIN FIXAtIoN oF PRostAte 
IN MoLd
The porous mold design enables fixation of the prostate in situ. 
The mold/prostate is removed from the canister and immersed 
in 1-L fixative solution in a narrow vessel placed on a magnetic 
stirrer overnight. The low density of the nylon mold provides 
FIGURe 4 | Prostate slicing in mold. The mold is stabilized in a cradle (C). 
The handle (H) and separate spacer (S) maintain two skin graft blades (B) at 
the same 5 mm spacing as the mold cutting planes.
FIGURe 3 | Apparatus for ex vivo imaging of the prostate immersed in 
saline. See text for design features description.
FIGURe 2 | Mold design features. See text for label descriptions.
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sufficient buoyancy for the prostate to float just below the liquid 
surface. Use of the stirrer enhances penetration of the fixative 
through the mold structure and into the prostate. Post fixation, 
the immersion solution is replaced with 1-L saline for 8 h to dilute 
the formalin which, at full strength, severely reduces the sample 
T2 leading to poor signal quality.
Formalin fixation leads to tissue shrinkage (17) and shape 
changes (18). Fixation of the prostate in the mold constrains any 
shape changes.
8. APPARAtUs FoR seCtIoNING 
PRostAte IN MoLd
Upon completion of fixation and ex vivo imaging, the prostate 
is sectioned for histological processing (Figure  4). The mold 
defines two cutting planes spaced 5 mm apart on either side of 
the imaging reference plane. Prior to cutting, the mold stabilizer 
braces (Figure 2) are removed with a scalpel blade, and the mold 
placed in a dedicated cradle (C). The two cuts on either side of the 
reference slice are made simultaneously using a pair of skin graft 
blades (R55170, Rocket Medical, Washington, UK) mounted in 
an SLS-printed handle (H). The handle and a detachable spacer 
(S) maintain the blades at 5-mm spacing that aids insertion of the 
blades into the slots in the top of the mold.
After cutting of the reference plane section, the mold is opened 
and the prostate removed. The base and apex volumes are then 
progressively sectioned at 5-mm thickness using a flat plate with 
5-mm high rails to guide the blade.
Whole mount tissue sections are processed according to 
standard laboratory protocol. These sections are cut from the 
prostate apex face of each block. Note that the reference plane 
landmarks in the mold are offset toward the apex to account for 
the histology slice position typically being closer to the apex side 
of each tissue section than to the base side.
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9. IMAGe ReGIstRAtIoN
There is a very wide range of 2D image registration methods that 
could be applied for alignment of the MRI and histology images. 
As the focus of this paper is on the apparatus used for prostate 
imaging and sectioning, we present here only an outline of the 
methods used to produce the example data presented in the 
figures.
Hematoxylin and eosin stained whole mount sections 
were digitally scanned with a 20× objective (Hamamatsu 
NanoZoomer). Histological images were downsampled to 0.25× 
and converted to grayscale for registration. The high-resolution 
ex vivo T2 MRI slice for registration was selected based on the 
mold landmarks. Registration to the corresponding histological 
slice used an intensity-based 2D rigid registration based on a 
block-matching strategy (19, 20) with the correlation coefficient 
as similarity measure. The ex vivo MRI was registered to the 
in  vivo MRI using 2D affine registration, restricting the block 
matching in the in vivo image to the prostate region using the 
contour from section 4.2.
10. sAMPLe ResULts
An example case is shown in Figure 5.
Registered MRI and histology slices are shown in Figure 6. 
Slicing artifacts, particularly near the urethra, are visible and 
may be corrected by additional non-rigid registration techniques. 
Nevertheless, the spatial correspondence between the ex vivo and 
histology images can be seen, including in the peripheral zone 
shape and in the outline of glandular regions within the transition 
zone. The peripheral zone partially collapses between in vivo and 
ex vivo imaging, but internal structures within the transition zone 
show correspondence.
11. LIMItAtIoNs ANd FUtURe 
dIReCtIoNs
The apparatus detailed here addresses many of the issues 
described in section 2 and extends previous methods by improv-
ing the alignment of in vivo and ex vivo imaging planes with each 
other and with histopathology sections. Nevertheless, a number 
of problems remain
•	 Prostate contouring from in vivo images. Contour delinea-
tion on the in vivo images aims to trace the expected surgical 
margins. These are normally close to the prostatic capsule 
but may vary case by case and the capsule is absent around 
the prostatic apex. Depending on the T2 image quality and 
characteristics of the individual prostate, it is sometimes 
difficult to discriminate the capsule from adjacent intra and 
extra-prostatic structures. One strategy to accommodate 
these uncertainties is to print multiple versions of the mold 
FIGURe 5 | Images from the reference slice and slices ±5 mm from the reference. Contours from the in vivo scan’s reference slice were aligned with the 
reference plane of the mold. The 8 channels in the reference plane were used to locate the reference slice for fresh scans at 3 and 9.4 T, as well as after fixation.
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